pharmaceutical safety
Investigation Reveals Safety Lapses and Regulatory Failures in Fatal Cough Syrup Contamination Case
Nov 21, 2025 04:14 pm CST
An exclusive investigation into the deaths of 24 children from contaminated cough syrup has uncovered serious safety breaches in India's pharmaceutical supply chain. The report details how improper handling of propylene glycol solvent, unauthorized repackaging by unlicensed distributors, and inadequate regulatory oversight may have allowed toxic diethylene glycol to contaminate Coldrif cough syrup, raising new concerns about quality control in India's $50 billion pharmaceutical industry.
Coldrif Cough Syrup Tragedy: 20 Children Dead as Sresan Pharma Owner Faces Police Custody
Oct 11, 2025 07:16 am CST
The owner of Sresan Pharma, Ranganathan, has been remanded to 10-day police custody following the deaths of 20 children across three districts in Madhya Pradesh allegedly linked to Coldrif cough syrup. As investigations intensify, the DCGI has issued nationwide directives for stricter pharmaceutical testing protocols while local chemists protest through an indefinite strike.
WHO Warns of Regulatory Gaps After Fatal Cough Syrup Contamination in India
Oct 09, 2025 01:10 pm CST
The World Health Organization has raised concerns about India's regulatory gaps in screening for toxic chemicals in medicines after contaminated cough syrups caused the deaths of 20 children in Madhya Pradesh and Rajasthan. WHO highlighted the potential international risk of such products being exported through unregulated channels, following the discovery of high levels of diethylene glycol in several cough syrup brands.
India's Drug Regulator Acknowledges Pharmaceutical Manufacturing Lapses Following Fatal Cough Syrup Incidents
Oct 09, 2025 12:51 am CST
India's top drug regulator has admitted serious deficiencies in pharmaceutical manufacturing practices after children died from suspected contaminated cough syrups. CDSCO investigations revealed manufacturers failing to test raw materials and finished products as required by law, leading to stricter enforcement measures nationwide. The scandal has damaged India's reputation as a global pharmaceutical supplier, with multiple states implementing emergency restrictions on cough medication distribution.
FAIMA Urges Health Ministry to Form Central Committee to Investigate Fatal Contaminated Cough Syrup Cases
Oct 08, 2025 09:07 pm CST
The Federation of All India Medical Association (FAIMA) has called for a central investigation committee to examine the deaths of over 20 children in Madhya Pradesh and Rajasthan linked to contaminated Coldrif cough syrup. The medical body emphasized the need for nationwide testing of pediatric medications, improved regulatory coordination, and protection of physicians from premature blame while ensuring pharmaceutical safety standards are enforced.
Medical Body Condemns Scapegoating of Doctor in Madhya Pradesh Cough Syrup Deaths Tragedy
Oct 08, 2025 07:36 pm CST
The Federation of All India Medical Association criticizes authorities for making a doctor the scapegoat in the Madhya Pradesh cough syrup tragedy that claimed 16 children's lives. FAIMA Chief Patron Dr. Rohan Krishnan argues that responsibility lies with regulatory bodies that approved the medication containing ingredients banned for young children, highlighting systemic failures in pharmaceutical safety oversight and government awareness campaigns.
Dangerous Diethylene Glycol Contamination Found in 'Coldrif' Cough Syrup: Health Ministry Confirms Safety Risk
Oct 04, 2025 05:44 pm CST
The Health Ministry has confirmed that 'Coldrif' cough syrup manufactured by Sresan Pharma in Tamil Nadu contains diethylene glycol (DEG) exceeding safe limits. This industrial solvent can cause severe kidney damage, liver failure, and death, particularly in children. Both Tamil Nadu and Madhya Pradesh have banned the product while authorities conduct comprehensive investigations at 19 manufacturing sites across six states.
Deadly Contamination: Madhya Pradesh Bans Coldrif Cough Syrup After 10 Deaths and Confirmed Diethylene Glycol Presence
Oct 04, 2025 05:16 pm CST
The Madhya Pradesh government has banned 'Coldrif' cough syrup after an NDTV report revealed it contained 48.6% Diethylene Glycol, a toxic industrial solvent. Ten deaths have been linked to the medication, with affected children showing symptoms consistent with DEG poisoning. All products from manufacturer Sresan Pharmaceuticals have been suspended pending investigation.
Rajasthan Suspends Drug Controller Following Children's Deaths Linked to Cough Syrup
Oct 04, 2025 02:13 pm CST
The Rajasthan government has suspended its state drug controller and halted distribution of all medications from Kaysons Pharma following reports of 11 children's deaths allegedly linked to contaminated cough syrup containing Dextromethorphan. An expert committee will investigate the matter while new safety measures are being implemented to protect public health.
Tamil Nadu Bans Coldrif Cough Syrup Following Child Fatalities in Multiple States
Oct 04, 2025 01:24 am CST
Tamil Nadu authorities have banned the sale of 'Coldrif' cough syrup manufactured by a Chennai-based pharmaceutical company after 11 children died in Madhya Pradesh and Rajasthan. Health officials have collected samples to test for Diethylene Glycol contamination while the Union Health Ministry has advised against prescribing cough medications to children under age 2.